Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01608750
NCT01608750
Unknown
Phase 4

The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia: Randomised, Double-blind, Placebo-controlled Trial.

Bezmialem Vakif University1 site in 1 country200 target enrollmentJune 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNonulcer Dyspepsia
InterventionsPantoprazolFolic Acid
DrugsPantoprazolFolic Acid

Overview

Phase
Phase 4
Intervention
Pantoprazol
Conditions
Nonulcer Dyspepsia
Sponsor
Bezmialem Vakif University
Enrollment
200
Locations
1
Primary Endpoint
Effectiveness of pantoprazole treatment in patients with functional dyspepsia measured by symptoms scale.
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

The aim of our study is to evaluate the effectiveness of proton pump inhibitor (PPI) treatment in patients with functional dyspepsia.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
June 2013
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Birol Baysal

Gastroenterologist

Bezmialem Vakif University

Eligibility Criteria

Inclusion Criteria

  • •aged 18-45 years with symptoms of dyspepsia,
  • •no evidence of organic disease.

Exclusion Criteria

  • •Patients with alarm symptoms,
  • •Severe concomitant illness,
  • •Pregnancy or lactation,
  • •Alcohol or drug abuse,
  • •Use of aspirin or other non-steroidal anti-inflammatory drugs antibiotics, H2 receptor blockers, bismuth, or proton pump inhibitors in the preceding two weeks

Arms & Interventions

pantoprazole

Intervention: Pantoprazol

folic acid

Intervention: Folic Acid

Outcomes

Primary Outcomes

Effectiveness of pantoprazole treatment in patients with functional dyspepsia measured by symptoms scale.

Time Frame: one year

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese PopulationGastroesophageal Reflux
NCT00516971Hospital Authority, Hong Kong200
Completed
Phase 3
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse EvaluationCardio-cerebrovascular Disease
NCT01051388Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan280
Unknown
Not Applicable
Therapeutic study of the proton- pump inhibitors resistant patients with Non-Erosive Reflux Diseaseon-Erosive Reflux Disease (NERD)Digestive SystemNon-Erosive Reflux Disease (NERD)
ISRCTN82345975Shimane University, Second Department of Internal Medicine (Japan)149
Completed
Phase 1
Effect of a Proton Pump Inhibitor on Gleevec® in Healthy VolunteersHealthy
NCT00446004University of Pittsburgh15
Unknown
Not Applicable
Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer BleedingBleeding Gastric UlcerBleeding Duodenal Ulcer
NCT02108756Chia Tai Tianqing Pharmaceutical Group Co., Ltd.272